Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
|
|
KINETA, INC. (PTI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/22/2022 |
8-K
| Asset disposition, Resignation/termination of a director|
Docs:
|
"Certificate of Amendment of Fifth Amended and Restated Certificate of Incorporation of the Company (formerly known as Yumanity Therapeutics, Inc.) related to the Reverse Stock Split",
"Certificate of Amendment of Fifth Amended and Restated Certificate of Incorporation of the Company (formerly known as Yumanity Therapeutics, Inc.) related to the Name Change",
"Fourth Amended and Restated By-laws of the Company",
"Kineta, Inc. 2022 Equity Incentive Plan and associated forms",
"Kineta Amended and Restated 2008 Stock Plan and associated forms (filed as 0 to the Company’s Registration Statement on Form S-4 (File No. 333-267127) as filed with the SEC on August 29, 2022 and incorporated herein by reference)",
"Kineta Amended and Restated 2008 Stock Plan and associated forms (filed as 0 to the Company’s Registration Statement on Form S-4 (File No. 333-267127) as filed with the SEC on August 29, 2022 and incorporated herein by reference)",
"Kineta Amended and Restated 2008 Stock Plan and associated forms (filed as 0 to the Company’s Registration Statement on Form S-4 (File No. 333-267127) as filed with the SEC on August 29, 2022 and incorporated herein by reference)",
"Letter to the Securities and Exchange Commission from PricewaterhouseCoopers LLP",
"Kineta Completes Reverse Merger with Yumanity Therapeutics",
"Unaudited condensed consolidated financial statements of Kineta for the nine months ended September 30, 2022 and 2021" |
|
| 09/14/2016 |
8-K
| Form 8-K - Current report |
|
|